Invesco Ltd.

IVZ Financial Services · Asset Management
Delayed 15 min
Last close
$28.80
Oct 16, 2026
52-week range
$20.67 — $33.66
-14% from high
Market cap
12.7B
Diluted basis
Dividend yield
3.0%
P/E
—
Trailing
Verdict status · Oct 16, 2026

Not yet scored

Filing.fyi has not computed forensic scores for IVZ yet. Scores appear after the company's next data refresh.

No verdict yet
RED DEEP Scores pending shown after the next data refresh
Composite Health
AI synthesis · written from this company's SEC filings · not investment advice

What the filing actually says.

AI · forensic preset

This synthesis rests only on a short set of annual financial facts, so it cannot yet give a full picture of Invesco Ltd. The reported revenue series runs from $6.89 billion in 2021 to $5.72 billion in 2023 and then rises to $6.38 billion in 2025, which is a recovery in sales over the last two years but not a return to the 2021 level. Operating income tells a harsher story. It fell from $1.79 billion in 2021 and $1.32 billion in 2022 to an operating loss of $434.8 million in 2023, returned to $832.1 million of operating income in 2024, and then moved to an operating loss of $695.7 million in 2025. Those swings are large relative to the revenue changes, which is the pattern a careful reader would want to explain using the filing itself. No forensic scores are on file, so this synthesis does not assess the Beneish M-Score, Piotroski F-Score, Altman Z-Score, or Fog Index, and it gives no values for them. The absence of scores means the screening signals a reader might normally check are unavailable here, not that they are favorable. The sector is labeled as asset management, but no segment, product, fund, or regulatory detail is provided, so this analysis cannot name specific business lines, legal matters, or debt instruments. Readers may want to look at the MD&A, the risk-factor section, and the notes on impairments and segment results in the company's annual report to understand what drove the 2023 and 2025 operating losses and whether those items are expected to recur.

Catalyst.The data on file does not include MD&A text, so the business drivers management cites cannot be described here. The reported figures show total revenues of $6.38 billion for 2025, up from $6.07 billion in 2024, an increase of about 5.1%. Over the same period, operating income moved from $832.1 million to an operating loss of $695.7 million. Net income for 2024 was $538 million, but 2025 net income is not in the data provided. The most recent results therefore show higher top-line sales alongside a sharp deterioration in operating profit.

Hidden risk.The most material tension is that revenue has grown while operating results have been negative in two of the last three reported years: an operating loss of $434.8 million in 2023 and an operating loss of $695.7 million in 2025. Revenue alone does not show whether costs, impairments, or other items drove these losses, and no risk-factor text is on file to explain them. Net income also swung from $683.9 million in 2022 to a loss of $333.7 million in 2023, then back to $538 million in 2024. Readers may want to look at the income statement notes and risk factors in the filing to see what caused the operating losses.

Market signals · from trading data, not filings

What traders are betting.

The scores above come from what IVZ reports to the SEC. These readings come from how traders are positioned in its shares. They change quickly, they can be wrong, and they are not part of the verdict.
Short interest Shares sold short · reported twice a month
5.3%
of the shares available to trade
Moderate
0%5% · 10% · 20%25%+

The metric

Shares that traders have borrowed and sold, betting the price will fall, and not yet bought back. Brokers report the total to FINRA twice a month. Days to cover divides it by the shares that change hands on a typical day.

Shares sold short
16.1M
Change since Aug 31
+30.2%
Days to cover
3.7

What it tells us

A noticeable minority of traders is betting that IVZ shares will fall.

Short sellers added to their bets: shares sold short grew 30.2% since the Aug 31 report.

At normal trading volume, short sellers would need about 3.7 days to buy back every borrowed share.

How investors use it

  • Squeeze watching. Some aggressive traders seek out heavily shorted stocks, betting that good news will force short sellers to buy back shares and push the price higher.
  • Hedging. Funds short one company to offset risk in another, often owning a stronger business and shorting a weaker one in the same industry.
  • Timing. Chart-based traders pair rising short interest with price patterns, such as a break below a level where buyers used to step in, to decide when to enter or exit.
  • Warning sign. Some owners treat a sharp rise in short interest as a red flag and respond by tightening stop-loss orders or holding smaller positions.

Lesson: short interest, explained →

Short-interest report for Sep 30, 2026, via Yahoo Finance. Reports come out about a week and a half after that date.

SEC filings · last 12 months

Quarterly report

The quarterly report (10-Q) and current reports (8-K) Invesco filed in the last 12 months, each linked to the original document on SEC EDGAR.

  • Oct 9, 2026
    8-K/A
    Current report (amended)Item 7.01: Regulation FD disclosure (investor materials)0
    EDGAR →
  • Oct 9, 2026
    8-K
    Current reportItem 7.01: Regulation FD disclosure (investor materials)0
    EDGAR →
  • Sep 10, 2026
    8-K
    Current reportItem 7.01: Regulation FD disclosure (investor materials)0
    EDGAR →
  • Aug 31, 2026
    8-K
    Current reportItem 5.02: Departure/appointment of officers or directors; Item 7.01: Regulation FD disclosure (investor materials)
    ★ Curriculum-relevant
    EDGAR →
  • Aug 11, 2026
    8-K
    Current reportItem 7.01: Regulation FD disclosure (investor materials)0
    EDGAR →
  • Aug 4, 2026
    10-Q
    Quarterly report0
    EDGAR →
  • Jul 28, 2026
    8-K
    Current reportItem 2.02: Results of operations (earnings)0
    EDGAR →
Further reading · curated for this filing

If this case caught your eye

Affiliate links — Filing.fyi earns a commission on Amazon purchases. We pick the books first, attach the link second.

Financial Shenanigans

Howard M. Schilit

Schilit's framework for the seven shenanigan types is the standard reference for the kind of MD&A pattern-matching this site does.

View on Amazon →

The Interpretation of Financial Statements

Benjamin Graham

The original — and still the clearest — explanation of why working-capital trends matter more than headline earnings.

View on Amazon →

Quality of Earnings

Thornton L. O'glove

Out of print, expensive, worth it. The chapter on receivables-vs-revenue divergence applies almost word-for-word to most distressed filings.

View on Amazon →